BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Chi-Med Initiates FRUTIGA, a Phase III Trial of Fruquintinib in Second-Line Gastric Cancer

  Fruquintinib is a highly selective and potent oral inhibitor of vascular endothelial growth factor receptors (“VEGFR”) 1, 2 and 3.

  October 31, 2017

   · 

  8 min read
• Business

  Pfizer Reports Third-Quarter 2017 Results

  Third-quarter 2017 revenues totaled $13.2 billion, an increase of $123 million, or 1% compared to the prior-year quarter, reflecting operational growth of $178 million, or 1%, slightly offset by the unfavorable impact of foreign exchange of $54 million.

  October 31, 2017

   · 

  37 min read
• Valeant Will Reduce Debt by Additional $125M

  Valeant today announced it put in notice to pay down an additional $125M of its senior secured term loans, using cash on hand.

  October 31, 2017

   · 

  2 min read
• BioForest

  Findings of NIH-Funded Pilot Study Suggest Home-Delivered Nutritional Meals May Lower Patient Readmission Rates and Improve Health Outcomes

  A wide variety of meals were available, catering to individualized personal tastes, and as a result, more than three quarters of the participants enjoyed the meals at least 80 percent of the days.

  October 31, 2017

   · 

  3 min read
• Policy

  Verastem Announces Regulatory Strategy for Duvelisib New Drug Application Following Guidance From FDA

  The Company expects to submit the duvelisib NDA during the first quarter of 2018.

  October 31, 2017

   · 

  8 min read
• Biotech Beach

  Elixir Medical Corporation Unveils Transformational DynamX™ Stent Featuring Adaptive Segments that Uncage the Stented Artery

  Elixir Medical Corporation unveiled for the first time its novel stent technology, DynamX, a bioadaptive drug eluting stent (BA-DES) platform at the Transcatheter Cardiovascular Therapeutics (TCT) conference in Denver.

  October 31, 2017

   · 

  3 min read
• Bio NC

  410 Medical Presents LifeFlow Simulation Data at ACEP17

  The goal of the study was to compare 410 Medical’s LifeFlow Rapid Infuser to pressure bag for administering fluid boluses in simulated pre-hospital and hospital settings.

  October 31, 2017

   · 

  2 min read
• Business

  Imprimis Pharma to Host its Third Quarter 2017 Financial Report Conference Call and Webcast on November 14, 2017 at 4:15 p.m. EST

  Imprimis today announced it will release third quarter 2017 financial results after the close of trading on Tuesday, November 14, 2017.

  October 31, 2017

   · 

  3 min read
• Business

  Bio-Techne Releases First Quarter Fiscal 2018 Results

  First quarter organic revenue increased by 8% to $144.6M.

  October 31, 2017

   · 

  24 min read
• BioCapital

  Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek™ 2017

  Now, Ethicon is partnering with Johnson & Johnson Health & Wellness Solutions to introduce a new digital platform and smartphone app offering resources and decision-making tools for patients considering weight loss surgery

  October 31, 2017

   · 

  8 min read